Given that late-onset AD is often associated with cholesterol dysregulation and dyslipidemia10, assays were performed to determine if the AICD-MAST4-FOXO1-RTKN2 pathway is perturbed in late-onset AD brains. This evidence concerns the gene MAST4 and Alzheimer disease.